Evidence map›Paper›PMID 34915187›Full record

Trial reportHeart rhythm2022

Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study.

Min-Young Kim, Clare Coyle, David R Tomlinson, Markus B Sikkel, Afzal Sohaib, Vishal Luther, Kevin M Leong, Louisa Malcolme-Lawes, Benjamin Low, Belinda Sandler and 16 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Heart rhythm, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02487654 (Ectopy Triggering Ganglionated Plexus Ablation to Prevent Atrial Fibrillation), which is not on this map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02487654 naactive not recruitingnot on this map

Ectopy Triggering Ganglionated Plexus Ablation to Prevent Atrial Fibrillation

TypeinterventionalSponsorImperial College LondonRan2017 to 2024Enrolled116ConditionsParoxysmal Atrial FibrillationArmsPulmonary vein isolation, Ganglionated plexus ablation
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pulmonary vein isolation plus adjunctive therapy for the treatment of atrial fibrillation: a systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Pooled it
  2. Convolutional neural network for real‑time localization of ganglionated plexi from bipolar intracardiac electrograms.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  3. Article
  4. Article
  5. Time-course changes in autonomic nervous system activity after pulsed-field ablation for paroxysmal atrial fibrillation: comparison with cryoballoon ablation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Pulmonary vein isolation versus focused ganglionic plexus ablation: a meta-analysis of randomized controlled trials.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  10. Review
  11. Article
  12. Ganglionated plexi ablation impact on atrial fibrillation mechanisms and outcomes in patients with low scar burden.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  13. Article
  14. Article
  15. Feasibility of mapping and ablating ectopy-triggering ganglionated plexus reproducibly in persistent atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  16. Article
  17. Article
  18. Cardiac Neuroanatomy and Fundamentals of Neurocardiology.Cardiac electrophysiology clinics · 2024
    Review
  19. Autonomic modulation impacts conduction velocity dynamics and wavefront propagation in the left atrium.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 4 institutions in 1 country.

Min-Young KimMyocardial Function Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Cardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.
Clare CoyleMyocardial Function Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Cardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.
David R TomlinsonCardiology Department, Derriford Hospital, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
Markus B SikkelMyocardial Function Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Afzal SohaibCardiology Department, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
Vishal LutherCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Kevin M LeongCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Louisa Malcolme-LawesCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Benjamin LowCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Belinda SandlerMyocardial Function Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Elaine LimCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Michelle ToddCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Michael FudgeCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Ian J WrightCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Michael Koa-WingCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Fu Siong NgCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Norman A QureshiCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Zachary I WhinnettCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Nicholas S PetersMyocardial Function Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Cardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.
Daniel NewcombCardiology Department, Derriford Hospital, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
Cherith WoodCardiology Department, Derriford Hospital, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
Gurpreet DhillonCardiology Department, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
Ross J HunterCardiology Department, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
Phang Boon LimCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Nicholas W F LintonCardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom; Department of Bioengineering, Imperial College London, London, United Kingdom.
Prapa KanagaratnamMyocardial Function Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Cardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom. Electronic address: p.kanagaratnam@imperial.ac.uk.
Imperial College Healthcare NHS Trust · GBDerriford Hospital · GBSt Bartholomew's Hospital · GBImperial College London · GB

Funding

British Heart Foundation FS/13/44/30291British Heart Foundation FS/13/73/30352British Heart Foundation FS/20/11/34750British Heart Foundation FS/CRTF/21/24183
6 · The paper itself

Abstract

backgroundThe ganglionated plexuses (GPs) of the intrinsic cardiac autonomic system may play a role in atrial fibrillation (AF).

objectiveWe hypothesized that ablating the ectopy-triggering GPs (ET-GPs) prevents AF.

methodsGANGLIA-AF (ClinicalTrials.gov identifier NCT02487654) was a prospective, randomized, controlled, 3-center trial. ET-GPs were mapped using high frequency stimulation, delivered within the atrial refractory period and ablated until nonfunctional. If triggered AF became incessant, atrioventricular dissociating GPs were ablated. We compared GP ablation (GPA) without pulmonary vein isolation (PVI) against PVI in patients with paroxysmal AF. Follow-up was for 12 months including 3-monthly 48-hour Holter monitors. The primary end point was documented ≥30 seconds of atrial arrhythmia after a 3-month blanking period.

resultsA total of 102 randomized patients were analyzed on a per-protocol basis after GPA (n = 52; 51%) or PVI (n = 50; 49%). Patients who underwent GPA had 89 ± 26 high frequency stimulation sites tested, identifying a median of 18.5% (interquartile range 16%-21%) of GPs. The radiofrequency ablation time was 22.9 ± 9.8 minutes in GPA and 38 ± 14.4 minutes in PVI (P < .0001). The freedom from ≥30 seconds of atrial arrhythmia at 12-month follow-up was 50% (26 of 52) with GPA vs 64% (32 of 50) with PVI (log-rank, P = .09). ET-GPA without atrioventricular dissociating GPA achieved 58% (22 of 38) freedom from the primary end point. There was a significantly higher reduction in antiarrhythmic drug usage postablation after GPA than after PVI (55.5% vs 36%; P = .05). Patients were referred for redo ablation procedures in 31% (16 of 52) after GPA and 24% (12 of 50) after PVI (P = .53).

conclusionGPA did not prevent atrial arrhythmias more than PVI. However, less radiofrequency ablation was delivered to achieve a higher reduction in antiarrhythmic drug usage with GPA than with PVI.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsGangliaHeart AtriaHumansProspective StudiesRecurrenceTreatment OutcomeAutonomic nervous systemGanglionated plexiGanglionated plexusesNeuromodulationParoxysmal atrial fibrillation

Identifiers

PMID34915187
PMCPMC8976158
OpenAlexW4200148747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.